Granzyme B is dispensable in the development of diabetes in non-obese diabetic mice

12Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Pancreatic beta cell destruction in type 1 diabetes is mediated by cytotoxic CD8+ T lymphoctyes (CTL). Granzyme B is an effector molecule used by CTL to kill target cells. We previously showed that granzyme B-deficient allogeneic CTL inefficiently killed pancreatic islets in vitro. We generated granzyme B-deficient non-obese diabetic (NOD) mice to test whether granzyme B is an important effector molecule in spontaneous type 1 diabetes. Granzyme B-deficient islet antigen-specific CD8+ T cells had impaired homing into islets of young mice. Insulitis was reduced in granzyme B-deficient mice at 70 days of age (insulitis score 0.043±0.019 in granzyme B-deficient versus 0.139±0.034 in wild-type NOD mice p&0.05), but was similar to wild-type at 100 and 150 days of age. We observed a reduced frequency of CD3+CD8+ T cells in the islets and peripheral lymphoid tissues of granzyme B-deficient mice (p&0.005 and p&0.0001 respectively), but there was no difference in cell proportions in the thymus. Antigen-specific CTL developed normally in granzyme B-deficient mice, and were able to kill NOD islet target cells as efficiently as wild-type CTL in vitro. The incidence of spontaneous diabetes in granzyme B-deficient mice was the same as wild-type NOD mice. We observed a delayed onset of diabetes in granzyme B-deficient CD8-dependent NOD8.3 mice (median onset 102.5 days in granzyme B-deficient versus 57.50 days in wild-type NOD8.3 mice), which may be due to the delayed onset of insulitis or inefficient priming at an earlier age in this accelerated model of diabetes. Our data indicate that granzyme B is dispensable for beta cell destruction in type 1 diabetes, but is required for efficient early activation of CTL. © 2012 Mollah et al.

References Powered by Scopus

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

1576Citations
N/AReaders
Get full text

Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells

781Citations
N/AReaders
Get full text

Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients

555Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Pathogenic mechanisms in type 1 diabetes: The islet is both target and driver of disease

57Citations
N/AReaders
Get full text

Cytocidal macrophages in symbiosis with CD4 and CD8 T cells cause acute diabetes following checkpoint blockade of PD-1 in NOD mice

39Citations
N/AReaders
Get full text

The serine protease granzyme B as an inflammatory marker, in relation to the insulin receptor cleavage in human obesity and type 2 diabetes mellitus

31Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Mollah, Z. U., Graham, K. L., Krishnamurthy, B., Trivedi, P., Brodnicki, T. C., Trapani, J. A., … Thomas, H. E. (2012). Granzyme B is dispensable in the development of diabetes in non-obese diabetic mice. PLoS ONE, 7(7). https://doi.org/10.1371/journal.pone.0040357

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

47%

Researcher 7

41%

Professor / Associate Prof. 2

12%

Readers' Discipline

Tooltip

Immunology and Microbiology 6

33%

Agricultural and Biological Sciences 5

28%

Medicine and Dentistry 4

22%

Biochemistry, Genetics and Molecular Bi... 3

17%

Save time finding and organizing research with Mendeley

Sign up for free